The Next Generation of NGS; What's Missing and What's Next



September 13, 2013

The DNA sequencing field has seen dramatic advances since the first draft of the human genome was published, with companies reporting ever faster and cheaper methods. However, despite the race to attain the $1000 genome producing a plethora of exciting technologies, CE is still being routinely used for targeted clinical sequencing for genetic testing and drug resistance testing for infectious disease. QuantuMDx is developing two sequencing technologies to address this; a portable, handheld DNA sequencing device for PGx and infectious disease applications, to provide an alternative to slow and relatively expensive CE DNA sequencing and a "LastGen 2.0" technology to take on Nanopore sequencing head on, dubbed, T2T (Telomere to Telomere).

Flow Chemistry

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.